Nano Labs Ltd announced its 2026 Annual General Meeting on November 24, 2026, in Hangzhou, China. The meeting will seek shareholder approval for a share consolidation (10-to-1), re-designation of shares into Class A and B, and a conditional share subdivision (1-to-10) based on share price thresholds. Additionally, the appointment of MaloneBailey, LLP as the independent auditor for 2026 will be proposed. These changes aim to optimize the company's capital structure and respond to market conditions, with effective dates within one year of approval.
Nano Labs' upcoming 2026 Annual General Meeting is announced as context. For readers following US stocks on Pluang, here is the market snapshot as of Oct 12, 2026 17:51 WIB: out of 150 priced US stocks, 76 rose and 66 fell. Notable movers include META at USD 730.58 with a 1-day change of +1.66% and a typical hold time of 128 days, JD at USD 27.50 with +1.51%, and FIRY at USD 12.25 with +1.49%.
Rezolve AI announced that Arthur Yao, their Group CFO, will participate in the Consumer & Lifestyle Panel at the Maxim Growth Summit 2026 on October 13. The panel will focus on the rise of agentic commerce and its effects on consumer and lifestyle se...
STMicroelectronics repurchased 346,538 of its ordinary shares on Euronext Paris between October 5 and 9, 2026, spending about €17 million at an average price of €49.24 per share. This buyback, representing 0.04% of its issued share capital, aims to f...
Freshworks Inc. has signed an agreement to acquire Torii, a leader in SaaS and AI spend management, to extend its Freshservice platform. This acquisition aims to provide IT teams with comprehensive visibility and control over software and AI usage, c...
This week, five major U.S. banks—JPMorgan Chase, Goldman Sachs, Wells Fargo, Citigroup, and Morgan Stanley—are set to release their third-quarter earnings. The reports come amid a challenging market environment where bank shares have declined due to ...
STERIS plc announced it will acquire Xodus Medical, a specialty surgical products company, for $2.1 billion, with the deal expected to close by December 31, 2026. The acquisition will expand STERIS's healthcare consumables portfolio, particularly in ...
